Jeffrey Cehelsky

Jeffrey Cehelsky

Company: Intellia Therapeutics

Job title: Vice President - Development Operations

Seminars:

8.30 Making the Leap to Phase 3 Studies: Overcoming Clinical Development & Operational Challenges 8:30 am

• Unpacking the treatment site selection and education process • Finding and working effectively with the right CRO partners • Key considerations for Phase 3 study trial design and operationsRead more

day: Day One AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.